Jianqiu Wu
Shanghai University of Traditional Chinese Medicine(CN)Jiangsu Cancer Hospital(CN)Yueyang Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders
Most-Cited Works
- → Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China(2017)247 cited
- → A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma(2019)154 cited
- → Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China(2020)99 cited
- → Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma(2022)69 cited
- → Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)(2021)62 cited
- → Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma